Temozolomide-induced myelodysplasia

Advances in Hematology

Volumn 2010, Issue , 2010, Pages

  Natelson, Ethan A ^a   Pyatt, David ^b  

^a Methodist Hospital Smith Tower ^*  (United States)

^b LLP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; TEMOZOLOMIDE;

ADULT; ARTICLE; ASTROCYTOMA; BLOOD CELL COUNT; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOGENETICS; DRUG INDUCED CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GRAND MAL SEIZURE; HUMAN; LEUKOCYTE DISORDER; LEUKOPENIA; MALE; MEGALOCYTOSIS; MICROSCOPY; MONOSOMY; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PRIORITY JOURNAL; RADIOTHERAPY; TEMPORAL LOBE; THROMBOCYTOPENIA; TUMOR BIOPSY; TUMOR RECURRENCE;

EID: 77954597341     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2010/760402     Document Type: Article

References (51)

1. Lichtman M. A., Battling the hematological malignancies: the 200 years war Oncologist 2008 13 2 126 138
2. Natelson E. A., Benzene-induced acute myeloid leukemia: a clinicians perspective American Journal of Hematology 2007 82 9 826 830
3. Deschler B., Lbbert M., Acute myeloid leukemia: epidemiology and etiology Cancer 2006 107 9 2099 2107
4. Leone G., Mele L., Pulsoni A., Equitani F., Pagano L., The incidence of secondary leukemias Haematologica 1999 84 10 937 945
5. Larson R. A., Le Beau M. M., Therapy-related myeloid leukaemia: a model for leukemogenesis in humans Chemico-Biological Interactions 2005 153-154 187 195
6. Praga C., Bergh J., Bliss J., Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide Journal of Clinical Oncology 2005 23 18 4179 4191
7. Kollmannsberger C., Beyer J., Droz J.-P., Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors Journal of Clinical Oncology 1998 16 10 3386 3391
8. Knight J. A., Skol A. D., Shinde A., Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility Blood 2009 113 22 5575 5582
9. Bolufer P., Collado M., Barragn E., Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia British Journal of Haematology 2007 136 4 590 596
10. Rund D., Krichevsky S., Bar-Cohen S., Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients Leukemia 2005 19 11 1919 1928
11. Borthakur G., Lin E., Jain N., Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia Cancer 2009 115 14 3217 3221
12. Singh Z. N., Huo D., Anastasi J., Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant American Journal of Clinical Pathology 2007 127 2 197 205
13. Orazi A., Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/ myeloproliferative diseases Pathobiology 2007 74 2 97 114
14. Irons R. D., Lv L., Gross S. A., Chronic exposure to benzene results in a unique form of dysplasia Leukemia Research 2005 29 12 1371 1380
15. Irons R. D., Gross S. A., Wang X. Q., Integrating WHO 20012008 criteria for the diagnosis of Myelodysplastic Syndrome (MDS): A case-case analysis of benzene exposure. Chemico-Biological Interactions. In press
16. Ruiz M. A., Augusto L. G. S., Vassallo J., Vigorito A. C., Lorand-Metze I., Souza C. A., Bone marrow morphology in patients with neutropenia due to chronic exposure to organic solvents (benzene): early lesions Pathology Research and Practice 1994 190 2 151 154
17. Linet M. S., Yin S.-N., Travis L. B., Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China Environmental Health Perspectives 1996 104 supplement 6 1353 1364
18. Kyle R. A., Pierre R. V., Bayrd E. D., Multiple myeloma and acute myelomonocytic leukemia The New England Journal of Medicine 1970 283 21 1121 1125
19. Van Leeuwen F. E., Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment Baillires Clinical Haematology 1996 9 1 57 85
20. Ellis R., Boggild M., Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it? Multiple Sclerosis 2009 15 4 505 508
21. Chamberlain M. C., Raizer J., Extended exposure to alkylator chemotherapy: delayed appearance of myelodysplasia Journal of Neuro-Oncology 2009 93 2 229 232
22. Khasraw M., Bell D., Wheeler H., Long-term use of temozolomide: could you use temozolomide safely for life in gliomas? Journal of Clinical Neuroscience 2009 16 6 854 855
23. Hegi M. E., Diserens A.-C., Gorlia T., MGMT gene silencing and benefit from temozolomide in glioblastoma The New England Journal of Medicine 2005 352 10 997 1003
24. Dunn J., Baborie A., Alam F., Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy British Journal of Cancer 2009 101 1 124 131
25. Cunningham J. M., Patnaik M. M., Hammerschmidt D. E., Vercellotti G. M., Historical perspective and clinical implications of the Pelger-Huet cell American Journal of Hematology 2009 84 2 116 119
26. Greene M. H., Young R. C., Merrill J. M., DeVita V. T., Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkins lymphoma Cancer Research 1983 43 4 1891 1898
27. Koukourakis G. V., Kouloulias V., Zacharias G., Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy Molecules 2009 14 4 1561 1577
28. Chakravarti A., Erkkinen M. G., Nestler U., Temozolomide-mediated radiation enhancement in glioblastoma: a report on underlying mechanisms Clinical Cancer Research 2006 12 15 4738 4746
29. Hansen R. J., Nagasubramanian R., Delaney S. M., Samson L. D., Dolan M. E., Role of O6 -methylguanine-DNA methyltransferase in protecting from alkylating agent-induced toxicity and mutations in mice Carcinogenesis 2007 28 5 1111 1116
30. Kaina B., Christmann M., Naumann S., Roos W. P., MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents DNA Repair 2007 6 8 1079 1099
31. Adema A. D., van der Born K., Honeywell R. J., Peters G. J., Cell cycle effects and increased adduct formation by temozolomide enhance the effect of cytotoxic and targeted agents in lung cancer cell lines Journal of Chemotherapy 2009 21 3 338 346
32. Hirose Y., Sano H., Molecular pharmacology on DNA methylating agent temozolomide Neurological Surgery 2007 35 2 117 129
33. Viola G., Cecconet L., Leszl A., Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition Cancer Chemotherapy and Pharmacology 2009 64 6 1235 1251
34. Singhal N., Selva-Nayagam S., Brown M. P., Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatmentcase study and review of literature Journal of Neuro-Oncology 2007 85 2 229 230
35. Villano J. L., Collins C. A., Manasanch E. E., Ramaprasad C., van Besien K., Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide Lancet Oncology 2006 7 5 436 438
36. George B. J., Eichinger J. B., Richard T. J., A rare case of aplastic anemia caused by temozolomide Southern Medical Journal 2009 102 9 974 976
37. Figueroa M. E., Skrabanek L., Li Y., MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation Blood 2009 114 16 3448 3458
38. Kil W. J., Cerna D., Burgan W. E., In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide Clinical Cancer Research 2008 14 3 931 938
39. Fadul C. E., Kingman L. S., Meyer L. P., A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiforme Journal of Neuro-Oncology 2008 90 2 229 235
40. Tentori L., Graziani G., Recent approaches to improve the antitumor efficacy of temozolomide Current Medicinal Chemistry 2009 16 2 245 257
41. Noronha V., Berliner N., Ballen K. K., Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literature Neuro-Oncology 2006 8 3 280 283
42. Perry J. R., Brown M. T., Gockerman J. P., Acute leukemia following treatment of malignant glioma Journal of Neuro-Oncology 1998 40 1 39 46
43. Su Y.-W., Chang M.-C., Chiang M.-F., Hsieh R.-K., Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma Journal of Neuro-Oncology 2005 71 3 315 318
44. Whysner J., Reddy M. V., Ross P. M., Mohan M., Lax E. A., Genotoxicity of benzene and its metabolites Mutation Research 2004 566 2 99 130
45. Morgan G. J., Alvares C. L., Benzene and the hemopoietic stem cell Chemico-Biological Interactions 2005 153-154 217 222
46. Stillman W. S., Varella-Garcia M., Irons R. D., The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19- bone marrow cells Experimental Hematology 2000 28 2 169 176
47. Wilbur S., Keith S., Faroon O., Toxicological Profile for Benzene 2007 Atlanta, Ga, USA U.S. Department of Health and Human Services
48. Brunning R. D., Orazi A., Germing U., Swerdlow S. H., Myelodysplastic syndromes/neoplasms, overview World Health Organization: Classification of Tumors of Haematopoietic and Lymphoid Tissues 2008 4th Lyon, France International Agency for Research on Cancer 88 93
49. Swaen G. M. H., Scheffers T., De Cock J., Slangen J., Drooge H., Leukemia risk in caprolactam workers exposed to benzene Annals of Epidemiology 2005 15 1 21 28
50. Constantini A. S., Quinn M., Consonni D., Zappa M., Exposure to benzene and risk of leukemia among shoe factory workers Scandinavian Journal of Work, Environment and Health 2003 29 1 51 59
51. Williams P. R., Panko J. M., Unice K., Brown J. L., Paustenbach D. J., Occupational exposures associated with petroleum-derived products containing trace levels of benzene Journal of Occupational and Environmental Hygiene 2008 5 9 565 574